Synthetic Biologics' (SYN) Management On Q1 2018 Results - Earnings Call Transcript | Latest News RSS feed

Synthetic Biologics' (SYN) Management On Q1 2018 Results - Earnings Call Transcript - Latest News


Synthetic Biologics' (SYN) Management on Q1 2018 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (NYSEMKT:SYN) Q1 2018 Earnings Conference Call May 8, 2018 4:30 PM ET Executives Vincent Perrone – Director-Corporate Communication Steven Shallcross – Acting Chief Executive ... read more

ImmunoPrecise Realigns Senior Management

VICTORIA, Nov. 20, 2017 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces the realignment of its senior management team ... Inc. and Synthetic Biologi... read more

Oral Proteins and Peptides Market, 2030

w=12 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Ca... read more

Looking for another news?


Synthetic Biologics Inc. (SYN) CEO Steve Shallcross on Q3 2018 Results - Earnings Call Transcript

Synthetic Biologics Inc. (NYSEMKT:SYN) Q3 2018 Earnings Conference ... our financial results for the period ending September 30, 2018. The release can be found on the Investors Relations section of ou... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us